BRUSSELS (Reuters) - Shares of Belgian biotech group Ablynx ( ABLX.BR ) will be suspended until 1030 local time (0930 GMT), following a 45 euros epr share bid by French pharma group Sanofi ( SASY.PA ), the Belgian market regulator said.
The shares were suspended to allow an “adequate dissemination of a press release”, the regulator said in a statement.
Reporting by Robert-Jan Bartunek; editing by Philip Blenkinsop
 